Veradermics To Review Phase 3 Study 304 Results For VDPHL01 In Male Pattern Hair Loss; Stock Up
(RTTNews) - Veradermics, Inc. (MANE), a late-stage biopharmaceutical company focused on therapies for pattern hair loss, announced it will review results from Part A of a Phase 3 clinical trial (Study 304) evaluating VDPHL01 in males with mild-to-moderate pattern hair loss. The c